PLAUR and neoplasm: Others report that miR-143 directly targets the uPAR 3′-UTR and that this interaction underlies the therapeutic anti-tumor potential of miR-143 replacement therapy in polymeric nanoparticles by systemic treatment of mice bearing subcutaneous PC-3 tumor xenografts (Wach et al., 2019).